Description
PNC-27 30mg is a chimeric research peptide explored for its potent, selective cytotoxicity against malignant cells. Engineered from the HDM-2-binding domain of p53 fused to a cell-penetrating leader sequence, PNC-27 disrupts tumor-cell membranes while leaving healthy cells largely unharmed. Synthesized from premium raw materials and rigorously purified, our PNC-27 offers exceptional consistency and reliability for advanced oncological investigations.
Key Features:
-
Manufactured under stringent GMP-compliant conditions to maximize purity and bioactivity.
-
Each lot is subjected to comprehensive HPLC and mass-spectrometry analysis for quality assurance.
-
Supplied as a lyophilized powder to preserve structural integrity during storage and transport.
Applications:
-
Elucidating mechanisms of HDM-2 interaction and membrane pore formation in tumor cells.
-
Assessing selective cytotoxicity and necrosis induction across diverse cancer lines.
-
Investigating synergistic potential with existing chemotherapeutic agents.
Specifications and Documentation
-
Material Safety Data Sheet (MSDS): Coming Soon.
-
Handling and Storage Instructions: Coming Soon.
PNC-27 30mg provides researchers with a precise tool to interrogate targeted anti-cancer strategies, paving the way for deeper insights into tumor-selective therapies.
There are no reviews yet.